JPS6334845B2 - - Google Patents

Info

Publication number
JPS6334845B2
JPS6334845B2 JP55025658A JP2565880A JPS6334845B2 JP S6334845 B2 JPS6334845 B2 JP S6334845B2 JP 55025658 A JP55025658 A JP 55025658A JP 2565880 A JP2565880 A JP 2565880A JP S6334845 B2 JPS6334845 B2 JP S6334845B2
Authority
JP
Japan
Prior art keywords
compound
reaction
aminocarbonyl
carbostyryl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55025658A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56122356A (en
Inventor
Takao Nishi
Tatsuyoshi Tanaka
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP2565880A priority Critical patent/JPS56122356A/ja
Priority to DE803049959T priority patent/DE3049959T1/de
Priority to AU59859/80A priority patent/AU532319B2/en
Priority to US06/261,177 priority patent/US4435404A/en
Priority to NLAANVRAGE8020199,A priority patent/NL185146C/xx
Priority to PH24106A priority patent/PH18532A/en
Priority to AT0909480A priority patent/AT381493B/de
Priority to PCT/JP1980/000122 priority patent/WO1981002421A1/ja
Priority to CH6674/81A priority patent/CH647765A5/de
Priority to ZA00803322A priority patent/ZA803322B/xx
Priority to KR1019800002229A priority patent/KR860002099B1/ko
Priority to PT71359A priority patent/PT71359B/pt
Priority to MX808865U priority patent/MX6752E/es
Priority to CA000353541A priority patent/CA1159068A/en
Priority to GB8018609A priority patent/GB2070588B/en
Priority to IT67888/80A priority patent/IT1129812B/it
Priority to ES492230A priority patent/ES492230A0/es
Priority to FI801843A priority patent/FI76321C/fi
Priority to BE0/200953A priority patent/BE883713A/fr
Priority to FR8012744A priority patent/FR2477149A1/fr
Priority to SE8102690A priority patent/SE461147B/sv
Priority to SU813280901A priority patent/SU1169535A3/ru
Priority to DK250381A priority patent/DK151956C/da
Publication of JPS56122356A publication Critical patent/JPS56122356A/ja
Priority to NO81813477A priority patent/NO160512C/no
Priority to SU823456112A priority patent/SU1395140A3/ru
Priority to KR1019840002957A priority patent/KR860002100B1/ko
Priority to AT0066885A priority patent/AT383594B/de
Publication of JPS6334845B2 publication Critical patent/JPS6334845B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP2565880A 1980-02-29 1980-02-29 Carbostyril derivative Granted JPS56122356A (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
JP2565880A JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative
DE803049959T DE3049959T1 (de) 1980-02-29 1980-06-04 Carbostyryl derivatives
AU59859/80A AU532319B2 (en) 1980-02-29 1980-06-04 Carbostyryl derivatives
US06/261,177 US4435404A (en) 1980-02-29 1980-06-04 Carbostyril derivatives
NLAANVRAGE8020199,A NL185146C (nl) 1980-02-29 1980-06-04 Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd.
PH24106A PH18532A (en) 1980-02-29 1980-06-04 Novel carbostyril derivatives and pharmaceutical compositions containing the same
AT0909480A AT381493B (de) 1980-02-29 1980-06-04 Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
PCT/JP1980/000122 WO1981002421A1 (en) 1980-02-29 1980-06-04 Carbostyryl derivatives
CH6674/81A CH647765A5 (de) 1980-02-29 1980-06-04 Carbostyrilderivate.
ZA00803322A ZA803322B (en) 1980-02-29 1980-06-04 Novel carbostyril
KR1019800002229A KR860002099B1 (ko) 1980-02-29 1980-06-05 카르보스티릴 유도체의 제조방법
CA000353541A CA1159068A (en) 1980-02-29 1980-06-06 Carbostyril derivatives
MX808865U MX6752E (es) 1980-02-29 1980-06-06 Procedimiento para preparar derivados de carboestirilos
PT71359A PT71359B (en) 1980-02-29 1980-06-06 Novel carbostyril derivatives
GB8018609A GB2070588B (en) 1980-02-29 1980-06-06 Carbostyril derivatives
IT67888/80A IT1129812B (it) 1980-02-29 1980-06-06 Carbostiril derivati particolarmente utili come medicamenti e procedimento per la loro preparazione
ES492230A ES492230A0 (es) 1980-02-29 1980-06-06 Un procedimiento para la preparacion de nuevos derivados de carbostirilo
FI801843A FI76321C (fi) 1980-02-29 1980-06-09 Foerfarande foer framstaelllning av ett terapeutiskt anvaendbart karbostyrilderivat och dess salt.
BE0/200953A BE883713A (fr) 1980-02-29 1980-06-09 Nouveau derives de carbostyrile, leur procede de preparation et leur application en therapeutique
FR8012744A FR2477149A1 (fr) 1980-02-29 1980-06-09 Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
SE8102690A SE461147B (sv) 1980-02-29 1981-04-29 Karbostyrilderivat och farmaceutisk komposition innehaallande dem
SU813280901A SU1169535A3 (ru) 1980-02-29 1981-05-11 Способ получени карбостирильных производных
DK250381A DK151956C (da) 1980-02-29 1981-06-09 Analogifremgangsmaade til fremstilling af carbostyrilderivater
NO81813477A NO160512C (no) 1980-02-29 1981-10-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
SU823456112A SU1395140A3 (ru) 1980-02-29 1982-06-18 Способ получени карбостирильных производных
KR1019840002957A KR860002100B1 (ko) 1980-02-29 1984-05-29 카르보스티릴 유도체의 제조방법
AT0066885A AT383594B (de) 1980-02-29 1985-03-06 Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2565880A JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative

Publications (2)

Publication Number Publication Date
JPS56122356A JPS56122356A (en) 1981-09-25
JPS6334845B2 true JPS6334845B2 (en, 2012) 1988-07-12

Family

ID=12171902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2565880A Granted JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative

Country Status (24)

Country Link
US (1) US4435404A (en, 2012)
JP (1) JPS56122356A (en, 2012)
KR (2) KR860002099B1 (en, 2012)
AT (1) AT381493B (en, 2012)
AU (1) AU532319B2 (en, 2012)
BE (1) BE883713A (en, 2012)
CA (1) CA1159068A (en, 2012)
CH (1) CH647765A5 (en, 2012)
DE (1) DE3049959T1 (en, 2012)
DK (1) DK151956C (en, 2012)
ES (1) ES492230A0 (en, 2012)
FI (1) FI76321C (en, 2012)
FR (1) FR2477149A1 (en, 2012)
GB (1) GB2070588B (en, 2012)
IT (1) IT1129812B (en, 2012)
MX (1) MX6752E (en, 2012)
NL (1) NL185146C (en, 2012)
NO (1) NO160512C (en, 2012)
PH (1) PH18532A (en, 2012)
PT (1) PT71359B (en, 2012)
SE (1) SE461147B (en, 2012)
SU (2) SU1169535A3 (en, 2012)
WO (1) WO1981002421A1 (en, 2012)
ZA (1) ZA803322B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
JP2753622B2 (ja) * 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5506239A (en) * 1991-08-23 1996-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelets aggregation inhibitory agent
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
CN102639512B (zh) 2009-08-21 2015-12-09 大塚制药株式会社 苯并[b][1,4]二氮杂*-2,4-二酮化合物的制备方法
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021522A (en) * 1963-05-10 1966-03-02 Ici Ltd 2-quinolone derivatives
DE1527937A1 (de) * 1966-12-10 1969-11-13 Blanc & Co Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens
JPS48103590A (en, 2012) * 1972-04-13 1973-12-25
JPS5082218A (en, 2012) * 1973-11-10 1975-07-03
JPS5310988B2 (en, 2012) * 1974-04-25 1978-04-18
JPS5318030B2 (en, 2012) * 1974-05-20 1978-06-13
FI59246C (fi) 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4313947A (en) 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS5273879A (en) * 1975-12-18 1977-06-21 Otsuka Pharmaceut Co Ltd Synthesis of ester derivatives
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives

Also Published As

Publication number Publication date
KR830002713A (ko) 1983-05-30
IT1129812B (it) 1986-06-11
NL185146C (nl) 1990-02-01
SE8102690L (sv) 1981-08-30
SU1395140A3 (ru) 1988-05-07
MX6752E (es) 1986-06-25
ZA803322B (en) 1982-01-27
FI801843A7 (fi) 1981-08-30
US4435404A (en) 1984-03-06
ES8105290A1 (es) 1981-05-16
AT381493B (de) 1986-10-27
AU532319B2 (en) 1983-09-22
NL8020199A (nl) 1981-12-01
FR2477149A1 (fr) 1981-09-04
GB2070588B (en) 1983-10-19
DK151956B (da) 1988-01-18
PT71359B (en) 1981-10-21
FI76321B (fi) 1988-06-30
DK250381A (da) 1981-09-03
AU5985980A (en) 1981-09-11
SE461147B (sv) 1990-01-15
JPS56122356A (en) 1981-09-25
ES492230A0 (es) 1981-05-16
CA1159068A (en) 1983-12-20
DE3049959T1 (de) 1982-07-29
ATA909480A (de) 1986-03-15
FI76321C (fi) 1988-10-10
FR2477149B1 (en, 2012) 1983-06-24
NO160512B (no) 1989-01-16
NO813477L (no) 1981-10-15
DE3049959C2 (en, 2012) 1993-07-08
KR860002100B1 (ko) 1986-11-25
SU1169535A3 (ru) 1985-07-23
IT8067888A0 (it) 1980-06-06
NO160512C (no) 1989-04-26
NL185146B (nl) 1989-09-01
GB2070588A (en) 1981-09-09
PT71359A (en) 1980-07-01
CH647765A5 (de) 1985-02-15
KR860002099B1 (ko) 1986-11-25
DK151956C (da) 1988-08-15
KR840004681A (ko) 1984-10-22
BE883713A (fr) 1980-12-09
WO1981002421A1 (en) 1981-09-03
PH18532A (en) 1985-08-09

Similar Documents

Publication Publication Date Title
KR970005927B1 (ko) 디아릴메틸피페리딘 또는 피페라진의 피리딘 및 피리딘 n-옥사이드 유도체, 이를 함유하는 약제학적 조성물 및 이의 제조방법
TWI339121B (en) 1-piperazine- and 1-homopiperazine-carboxylate derivatives, preparation and therapeutic application thereof
US4404203A (en) Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
SE432252B (sv) Tetrazolyl-alkoxi-karbostyrilderivat
US4313947A (en) Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
JPS6320235B2 (en, 2012)
WO2006004589A2 (en) 3-aryl-5,6-disubstituted pyridazines
WO2003060475A2 (en) Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
JPS6334845B2 (en, 2012)
KR20120018813A (ko) 글루코코티코이드 수용체 작용제
JP7507162B2 (ja) 治療薬としてのｃＧＡＳ活性の阻害剤
JP2006508894A (ja) Ｃ５ａ受容体調節因子としての置換テトラヒドロイソキノリン
US7169775B2 (en) Amino methyl imidazoles as C5a receptor modulators
WO2005007087A2 (en) Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators
US5929074A (en) Pyridazinone derivatives with pharmaceutical activity
JPH0135827B2 (en, 2012)
RU2160735C2 (ru) Бензопираны, способ их получения, промежуточные соединения и фармацевтические композиции
US6858637B2 (en) Substituted biaryl amides as C5a receptor modulators
JPS64397B2 (en, 2012)
US4600710A (en) β-Adrenergic receptor agonist alkylaminoalkyl pyridinemethanol derivatives
JPS60218377A (ja) ４−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
JPS6127370B2 (en, 2012)
JPS644518B2 (en, 2012)
EP1745024A1 (en) 1-aryl-4-substituted isoquinolines
JPS6340429B2 (en, 2012)